GLOBALLY CONNECTED MEDICINAL CANNABIS GROUP
Health House International Limited was founded to pursue opportunities in the burgeoning global medicinal cannabis market.
Since 2014, the Board and founding shareholders of the Company have been pioneers in the Global medicinal cannabis sector establishing a number of publicly-listed companies including AusCann Group, Zelda Therapeutics and CannPal Animal Therapeutics.
Medigrowth is an Australian medicinal cannabis biotech with multi-disciplinary research involvement spanning plant science & next-gen technologies in biomedical analysis. Medigrowth is driven by a deep passion to improve quality of life for Australian patients. Industry partnership and university-led Australian Research Council Initiatives ensures Medigrowth continues the commitment to development and discovery.
Humacology crafts Australia’s most effective and affordable medicinal cannabis, replete with our proprietary blend of terpenes to aid in their efficacy, Crafted by Australian doctors for Australian patients, Humacology believes in the power of nature to heal.
Levin Health is an Australian sports science company focused on researching, developing, and commercialising a range of Medicinal Cannabis products initially for the treatment of pain, mental health disorders and sport-related ailments. Their purpose is to help get people back to improve their lifestyle.
Little Green Pharma was the first medical cannabis company in Australia to produce locally grown medical-grade cannabis products. Their medicinal cannabis products include a range of oils and dry cannabis flower tested to stringent Australian quality standards. Little Green Pharma also works closely with medical practitioners to assist them with applications for medical cannabis products; saving patients time and money.
Ananda Hemp offers high-quality products made with full spectrum CBD oil extracted from 100% Kentucky-grown hemp. Every plant that goes into their high-end line of CBD products is cultivated using organic farming practices. They also contain an array of cannabinoids and hundreds of bioactive phytonutrients from the hemp – resulting in a formula that is truly deserving of the title ‘full spectrum’.
The Australian Maali range is sun grown, sustainably in living soil in Regional Victoria, with a range of flower formulations offering patients a variety of clinical effects. The cannabis flower is of highest quality, under Australian GMP and depending on the dry cannabis flower prescribed, will also contain a unique mix of terpenes to reinforce cannabinoid therapy for patients.
Cann Pharmaceutical Australia (CPA) was the first Australian company to obtain a joint venture with a licensed medicinal cannabis company in Israel. Now a subsidiary of Better™ – a pioneer in the Israeli cannabis industry known for its advanced cultivation techniques – CPA’s mission is to address specific unmet patient needs based on the best available clinical research and development.
Heyday doctors carefully select the highest quality strains to develop medicines that are patient centred, efficacious and unique. The Heyday range of full spectrum cannabis oil and flower medicines are as good for Aussie patients as they are for the planet. Heyday flowers is sun grown in rural Victoria, some in polytunnels, some outdoors – using up to 96x less energy than indoor grows. Heyday flower is grown in living soil, with only local, organic compost added and the grow facility uses regenerative farming practices. Heyday medicines are AU GMP, high quality and fresh.
Zelira is a global biopharmaceutical company researching, developing, and marketing clinically validated cannabinoid-based medicines. Zelira are committed to world class science and the clinical validations of cannabinoid-based medicines. The company’s focus is on specific conditions, like chronic insomnia and autism spectrum disorder (ASD), and delivering solutions to patients who are no longer receiving a benefit from their conventional treatments.
Satipharm CBD Advanced capsules have been specifically developed to maximise bioavailability, resulting in significantly higher amounts of CBD absorbed. The capsules are available in two strengths with Gelpell technology to ensure cannabinoid stability and consistent dosing and absorption.
IX Biopharma has developed a range of sublingual wafers containing cannabidiol (CBD) and tetrahydrocannabinol (THC) by using its patented sublingual delivery technology, WaferiX™, Xativa™ CBD, Hypera™ THC each contain a nano-emulsion of highly bioavailable cannabis extract designed for rapid under-the-tongue absorption.
Australian Natural Therapeutics Group (ANTG) is Australia’s first GACP & GMP accredited medicinal flower cultivation and manufacturing facility. It is Australian grown and made, cultivated in NSW, with all natural, renewable medium, without harmful pesticides. ANTG’s aim is for all Australians to benefit from high-quality, affordable and locally produced medicines.
Dragonfly Biosciences CBD is 100% organic and THC-Free. Our GMP and GAP approved facilities allow us to manage the production process from ‘seed to shelf’, providing only the best quality CBD products that you can trust. Our extraction method is ethanol based and as ethanol is produced from plants by natural means, it is the purest way to derive CBD from the Cannabis plant.
Turkken is Australia’s number one Halal-certified GMP medical cannabis oil company. Australian owned and operated. Made using only Australian flower. Export ready.
As a soil-to-soil company and a leader in plant-based wellness, we take pride in having full control over the processing of our hemp and the resultant raw materials. We use advanced technologies for extraction and manufacturing, exclusive formulations, and third-party lab testing to give our customers proprietary products and peace of mind. This is the Botanic Wellness differences.
Sativite grow and distribute premium medicinal cannabis products – including selected varieties of high-quality, organically and sustainably grown dried flower and broad-spectrum extracts and oils with a range of cannabinoid profiles, as well as innovative cannabis-based medicines and delivery devices from leading licensed suppliers worldwise.
Timeline: Towards a Legal Medicinal Cannabis Market
California passes Proposition 215. It becomes the first US state to legalise medicinal cannabis.
Portugal decriminalises the use of all drugs.
Canada passes the Medicinal Marijuana Access Program, which allows clinicians to prescribe medicinal cannabis.
Montana becomes tenth US state to legalise medicinal cannabis.
Israel approves the first government sanctioned cannabis growing operations.
Colorado & Washington
Colorado and Washington become the first two states to legalise the recreational use of cannabis.
UK-based GW Pharmaceuticals, listed on the AIM London market, dual lists on the US NASDAQ.
Canada introduces the Medical Purposes Regulations, which lets patients access the drug from licensed producers.
The Italian parliament signs a motion to legalise cannabis.
Canopy Growth becomes the first cannabis stock to list on the Toronto Stock Exchange.
Germany passes a law legalising the use of cannabis for medical purposes.
Israel announces it will exports of medicinal cannabis.
Sativa becomes the UK’s first medical cannabis investment vehicle to be listed on the NEX Exchange.
Poland votes in favour of legalising medicinal cannabis.
Canada’s Aurora Cannabis and CanniMed Therapeutics $3.2 billion merger becomes the industry’s biggest M&A deal.
Canada’s Cronos Group becomes the first cannabis company to list on the US NASDAQ.
UK Home Secretary Sajid Javid changes the classification of medicinal cannabis to Schedule 2.
Medicinal cannabis available on prescription in the UK.